Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism

Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism

Show other versions (1)

<p align="LEFT">The paper evaluates the impact of hormone replacement therapy (HRT) with androgens on cardiac metabolic indicators in men with high cardiovascular risk (CVR) and androgen deficiency state. An open-label randomized clinical trial enrolled 52 men aged 30–64 years with h...

Full description

Bibliographic Details
Main Authors:	M. N. Mamedov, G. G. Sharvadze, A. A. Yevdokimova
Format:	Article
Language:	Russian
Published:	ABV-press 2014-12-01
Series:	Andrologiâ i Genitalʹnaâ Hirurgiâ
Subjects:	androgen-deficiency state transdermal gel with testosterone cardiac metabolic risk factors
Online Access:	http://agx.abvpress.ru/index.php/jour/article/view/84

Similar Items

Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism
by: M. N. Mamedov, et al.
Published: (2014-12-01)

Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)
by: Kushner Harvey, et al.
Published: (2011-11-01)

Complex application of certain micronatrients in men with androgen deficiency and pathosprimes
by: A. S. Minukhin, et al.
Published: (2018-02-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
by: Galina A. Melnichenko, et al.
Published: (2019-06-01)

Possibility of the use of herbal medicines in steroidogenesis in hypogonadal men
by: A. B. Bat’ko, et al.
Published: (2016-07-01)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
by: Nandini Shankara Narayana, et al.
Published: (2021-07-01)

Androgens and cardiac diseases
by: Vittorio Bianchi, et al.
Published: (2013-12-01)

Testosterone undecanoate effects on cardiovascular risk factors in men with metabolic syndrome
by: A. L. Vertkin, et al.
Published: (2008-10-01)

Could erectile dysfunction be a marker of atherosclerotic cardiovascular disease?
by: G. G. Sharvadze, et al.
Published: (1970-01-01)

CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA
by: A. Ya. Kravchenko, et al.
Published: (2016-01-01)

Hypogonadism in Exercising Males: Dysfunction or Adaptive-Regulatory Adjustment?
by: Anthony C. Hackney
Published: (2020-01-01)

A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus
by: Pankaj Kumar Agarwal, et al.
Published: (2017-01-01)

The Prevalence of Hypogonadism and the Effectiveness of Androgen Administration on Body Composition in HIV-Infected Men: A Meta-Analysis
by: Daniele Santi, et al.
Published: (2021-08-01)

Clomiphene citrate treatment outcomes in Taiwanese hypogonadal men: A single-center preliminary report
by: Jiun-Siang Tan, et al.
Published: (2017-03-01)

How do we define “castration” in men on androgen deprivation therapy?
by: Sarin Itty, et al.
Published: (2020-01-01)

Influence of hypothyroidism in men on androgenic function
by: T.I. Krytskyi
Published: (2018-11-01)

Effect of Korean Herbal Formula (Modified Ojayeonjonghwan) on Androgen Receptor Expression in an Aging Rat Model of Late Onset Hypogonadism
by: Sae Woong Choi, et al.
Published: (2019-01-01)

Late-onset hypogonadism: Review of the problem
by: Požarskis Anatolijs, et al.
Published: (2010-01-01)

EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON QUALITY OF LIFE OF TYPE 2 DIABETES PATIENTS AND ANDROGEN DEFICIENCY
by: V. N. Vasilkova, et al.
Published: (2016-03-01)

Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?
by: Jarecki P, et al.
Published: (2019-10-01)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
by: Daniel A Shoskes, et al.
Published: (2015-12-01)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
by: Kishore M Lakshman, et al.
Published: (2009-10-01)

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
by: Yu Seob Shin, et al.
Published: (2019-02-01)

Improvement of Testicular Steroidogenesis Using Flavonoids and Isoflavonoids for Prevention of Late-Onset Male Hypogonadism
by: Luc J. Martin, et al.
Published: (2020-03-01)

Serum Testosterone and Cortisol Concentrations After Single-Dose Administration of 100-Mg Transdermal Testosterone in Healthy Men
by: Andrei A. Puiu, et al.
Published: (2019-11-01)

INTEGRATED ASSESSMENT OF THE SUBSTANTIATION FOR MEDICAL CARE TECHNOLOGIES IN TYPE 2 DIABETES PATIENTS WITH ANDROGEN DEFICIENCY
by: V. N. Vasilkova, et al.
Published: (2017-08-01)

Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
by: Jin Wook Kim
Published: (2020-05-01)

Selective androgen receptor modulators for the treatment of late onset male hypogonadism
by: Christopher C Coss, et al.
Published: (2014-04-01)

Evolution of Guidelines for Testosterone Replacement Therapy
by: Hyun Jun Park, et al.
Published: (2019-03-01)

Sarcopenia and androgens: A link between pathology and treatment
by: Carla eBasualto-Alarcón, et al.
Published: (2014-12-01)

A place of androgen deficiency in a clinical portrait of the modern urological patient
by: I. A. Tyuzikov, et al.
Published: (2014-11-01)

A place of androgen deficiency in a clinical portrait of the modern urological patient
by: I. A. Tyuzikov, et al.
Published: (2014-11-01)

Testosterone and cardiovascular risk: myths and new truth about cardiological safety of androgen replacement therapy in men
by: S. Yu. Kalinchenko, et al.
Published: (2014-12-01)

Testosterone and cardiovascular risk: myths and new truth about cardiological safety of androgen replacement therapy in men
by: S. Yu. Kalinchenko, et al.
Published: (2014-12-01)

Ageing male and testosterone: Current status and treatment guidelines
by: S S Vasan
Published: (2006-01-01)

The role of hypogonadism in Klinefelter Syndrome
by: Christian Høst, et al.
Published: (2014-04-01)

Measurement of salivary testosterone in adolescents and young men with Duchenne muscular dystrophy
by: Yolanda Alins Sahun, et al.
Published: (2021-04-01)

Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
by: Abraham Morgentaler, et al.
Published: (2015-04-01)

Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy
by: Robert M. Coward, et al.
Published: (2010-12-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
by: Galina Afanas'evna Melnichenko, et al.
Published: (2017-06-01)